Andere Sprachen

16.04. Redcare Pharmacy : Supervisory Board Rotation Schedule Updated on 16/04/2026
16.04. Redcare Pharmacy : Remuneration Policy Managing Board Updated on 16/04/2026
16.04. Redcare Pharmacy : 2026 Stock Option Plan (Managing Board) Updated on 16/04/2026
16.04. Redcare Pharmacy's Annual General Meeting 2026: All agenda items approved; Anja Hendel, Max Müller and Peter Schmid von Linstow new members of the Supervisory Board.
16.04. Redcare Pharmacy N.V. Announces Board Appointment, Effective April 15, 2026
08.04. Bourse Zurich: le SMI s'envole après le cessez-le-feu en Iran
08.04. Global markets live: Exxon Mobil, Delta Air Lines, Ford, AppLovin, Shell…
08.04. Redcare Pharmacy dévoile des données trimestrielles préliminaires très rassurantes
08.04. Redcare Pharmacy Q1 sales EUR 848 million
08.04. Redcare Pharmacy in Q1: non-Rx growth rebounds in Germany, while strong Rx growth continues.
08.04. Redcare Pharmacy Nv Reports Preliminary Unaudited Revenue Result for First Quarter of 2026
31.03. U.S. Futures Rise, European Stocks Mostly Down
19.03. Redcare Pharmacy : N.V., Jaarlijkse financiële verslaggeving
11.03. Redcare Pharmacy : UBS Group AG - Redcare Pharmacy N.V. - Venlo
11.03. Redcare Pharmacy : UBS Group AG - Redcare Pharmacy N.V. - Venlo
09.03. Redcare Pharmacy : Transcript Earnings Call FY 2025
09.03. Redcare Pharmacy : Transkript Earnings Call FY 2025 (Englisch)
09.03. Redcare Pharmacy : publishes inaugural Climate Transition Plan with new emissions targets
06.03. Redcare Pharmacy soutenu par des achats à bon compte malgré Berenberg
05.03. Redcare Pharmacy : UBS Group AG - Redcare Pharmacy N.V. - Venlo
05.03. Redcare Pharmacy : UBS Group AG - Redcare Pharmacy N.V. - Venlo
04.03. Global markets live: Goldman Sachs, Meta, Intel, Moderna, Adidas…
04.03. Redcare Pharmacy NV Reports Earnings Results for the Full Year Ended December 31, 2025
04.03. Redcare Pharmacy sanctionné en bourse après des objectifs trop prudents
04.03. U.S. Futures Down, European Stocks Up
Keine Ergebnisse zu dieser Suche